6.97
前日終値:
$6.99
開ける:
$7
24時間の取引高:
20,957
Relative Volume:
0.10
時価総額:
$160.85M
収益:
$52.55M
当期純損益:
$-23.69M
株価収益率:
-7.4149
EPS:
-0.94
ネットキャッシュフロー:
$-15.29M
1週間 パフォーマンス:
-3.60%
1か月 パフォーマンス:
+2.35%
6か月 パフォーマンス:
+47.98%
1年 パフォーマンス:
+276.76%
Exagen Inc Stock (XGN) Company Profile
XGN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
XGN
Exagen Inc
|
6.97 | 160.85M | 52.55M | -23.69M | -15.29M | -0.94 |
![]()
TMO
Thermo Fisher Scientific Inc
|
410.77 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
200.49 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
528.90 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
119.04 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
157.63 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2022-08-05 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
2021-10-15 | 再開されました | Cowen | Outperform |
2021-04-15 | 開始されました | Canaccord Genuity | Buy |
2020-11-10 | 開始されました | KeyBanc Capital Markets | Overweight |
2020-10-08 | 開始されました | BTIG Research | Buy |
2020-06-02 | 再開されました | Cantor Fitzgerald | Overweight |
2019-10-14 | 開始されました | Cantor Fitzgerald | Overweight |
2019-10-14 | 開始されました | Cowen | Outperform |
2019-10-14 | 開始されました | William Blair | Outperform |
すべてを表示
Exagen Inc (XGN) 最新ニュース
Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World
Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World
Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks
Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World
XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus
Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World
Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa
Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria
Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World
Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st
Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World
Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail
Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus
Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada
Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com
Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World
Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus
Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus
Exagen prices public offering of common stock - MSN
Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus
Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire
Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus
Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan
Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st
Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Exagen sets price for public stock offering at $5.25 per share - Investing.com Nigeria
William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World
Exagen prices 3.35M shares at $5.25 per share in public offering - TipRanks
Exagen Prices $17.6 Million Public Offering; Shares Down - marketscreener.com
Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share - marketscreener.com
Exagen (XGN) Sets Price for Public Offering of Common Shares | XGN Stock News - GuruFocus
Exagen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Exagen Inc. Prices Public Offering of Common Stock | XGN Stock News - GuruFocus
Exagen Inc. Prices Public Offering of Common Stock - Bluefield Daily Telegraph
William Blair Estimates Exagen’s Q1 Earnings (NASDAQ:XGN) - Defense World
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Exagen announces common stock offering, no amount given - TipRanks
Exagen Inc (XGN) 財務データ
収益
当期純利益
現金流量
EPS
Exagen Inc (XGN) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
大文字化:
|
ボリューム (24 時間):